FDA grants SeaStar Medical breakthrough device designation for ICU SCD therapy
FDA granted SeaStar Medical a Breakthrough Device Designation for its SCD therapy to treat hyperinflammation in adult patients with sepsis or a septic condition.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.